AU2008900631A0 - Oral insulin composition and delivery - Google Patents
Oral insulin composition and deliveryInfo
- Publication number
- AU2008900631A0 AU2008900631A0 AU2008900631A AU2008900631A AU2008900631A0 AU 2008900631 A0 AU2008900631 A0 AU 2008900631A0 AU 2008900631 A AU2008900631 A AU 2008900631A AU 2008900631 A AU2008900631 A AU 2008900631A AU 2008900631 A0 AU2008900631 A0 AU 2008900631A0
- Authority
- AU
- Australia
- Prior art keywords
- delivery
- oral insulin
- insulin composition
- composition
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
Publications (1)
Publication Number | Publication Date |
---|---|
AU2008900631A0 true AU2008900631A0 (en) | 2008-02-28 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL275854A (en) | Pharmaceutical composition and administration thereof | |
HRP20180653T1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING desPro36Exendin-4(1-39)-Lys6-NH2 AND METHIONINE | |
IL207569A0 (en) | Compositions and methods for drug delivery | |
HK1218874A1 (en) | Dermal delivery | |
EP2419670B8 (en) | Delivery method and compositions | |
WO2009133352A3 (en) | Lipid composition | |
EP2074140B8 (en) | Fibrillation-resistant insulin and insulin analogues | |
EP2371406A4 (en) | Syringe | |
IL215608A0 (en) | Drug delivery composition | |
IL198911A0 (en) | Drug delivery | |
IL206835A0 (en) | Methods and compositions for oral administration of insulin | |
IL195764A0 (en) | Compositions and methods for drug delivery | |
ZA201008887B (en) | Oral compositions and uses thereof | |
ZA201007920B (en) | Oral compositions and uses thereof | |
EP2010162A4 (en) | Drug delivery composition | |
EP2236149A4 (en) | Medicinal composition | |
GB0823497D0 (en) | Immunogenic composition and use thereof | |
EP2035031A4 (en) | Insulin composition | |
HK1142278A1 (en) | Nucleic acid complex and nucleic acid delivery composition | |
AU2008900631A0 (en) | Oral insulin composition and delivery | |
AU2007900629A0 (en) | Oral insulin composition and delivery | |
EP2236135A4 (en) | Stable pharmaceutical composition | |
AU2008905920A0 (en) | Anaesthetic delivery means | |
AU2007902486A0 (en) | Insulin formulations | |
AU2007904647A0 (en) | Pharmaceutical Compound and Composition |